1. Home
  2. AOD vs YDES Comparison

AOD vs YDES Comparison

Compare AOD & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo abrdn Total Dynamic Dividend Fund of Beneficial Interest

AOD

abrdn Total Dynamic Dividend Fund of Beneficial Interest

HOLD

Current Price

$9.62

Market Cap

970.0M

Sector

Finance

ML Signal

HOLD

YDES

YD Bio Limited Ordinary Shares

N/A

Current Price

$13.15

Market Cap

1.1B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
AOD
YDES
Founded
2006
2013
Country
United Kingdom
Taiwan
Employees
N/A
N/A
Industry
Investment Managers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
970.0M
1.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AOD
YDES
Price
$9.62
$13.15
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
423.5K
87.4K
Earning Date
01-01-0001
09-30-2025
Dividend Yield
12.95%
N/A
EPS Growth
213.63
N/A
EPS
1.93
N/A
Revenue
$72,962,082.00
$510,360.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$4.44
N/A
Revenue Growth
N/A
45.76
52 Week Low
$6.99
$5.30
52 Week High
$9.14
$31.00

Technical Indicators

Market Signals
Indicator
AOD
YDES
Relative Strength Index (RSI) 59.37 N/A
Support Level $9.19 N/A
Resistance Level $9.67 N/A
Average True Range (ATR) 0.11 0.00
MACD 0.03 0.00
Stochastic Oscillator 89.69 0.00

Price Performance

Historical Comparison
AOD
YDES

About AOD abrdn Total Dynamic Dividend Fund of Beneficial Interest

Aberdeen Total Dynamic Dividend Fund is a diversified, closed-end management investment company. Its investment objective is to seek high current dividend income. The company also focuses on the long-term growth of capital as a secondary investment objective. The fund invests in foreign securities, including direct investments in securities of foreign issuers and investments in depositary receipts that represent indirect interests in securities of foreign issuers. Its portfolio consists of securities from Information Technology, Financial, Healthcare, and Industrials among other sectors.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: